Intercure (INCR) CFO discloses option grants and share stake

Rhea-AI Filing Summary

Intercure Ltd. Chief Financial Officer Amos Cohen filed an initial ownership report showing his existing equity stake in the company. He directly holds Ordinary Shares plus several series of employee share options (right to buy) over Ordinary Shares.

The options cover 134,708 underlying Ordinary Shares expiring on March 14, 2027, 95,292 expiring on August 30, 2026, and 230,000 expiring on May 15, 2026, all at an exercise price of $1.94 per share. The filing also shows 79,947 Ordinary Shares held directly.

Footnotes explain the exercise price is based on a current price of NIS 5.938 per share, converted using an exchange rate of NIS 3.060 to $1.00 as of April 14, 2026. Two option grants were fully vested by March 14, 2025 and August 31, 2025, while the May 15, 2022 grant vests quarterly over four years.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Cohen Amos

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Employee share options (right to buy)	--	--	--
holding	Employee share options (right to buy)	--	--	--
holding	Employee share options (right to buy)	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Employee share options (right to buy) — 134,708 shares (Direct); Ordinary Shares — 79,947 shares (Direct)

Footnotes (1)

1. The options were granted on March 14, 2021, and the current exercise price is NIS 5.938 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 3.060 to USD $1.00 as of April 14, 2026, resulting in an exercise price of $1.94 per share. The options became fully vested as of March 14, 2025. The options were granted on August 31, 2021, and the current exercise price is NIS 5.938 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 3.060 to USD $1.00 as of April 14, 2026, resulting in an exercise price of $1.94 per share. The options became fully vested as of August 31, 2025. The options were granted on May 15, 2022, and the current exercise price is NIS 5.938 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 3.060 to USD $1.00 as of April 14, 2026, resulting in an exercise price of $1.94 per share. The options vest on a quarterly basis over four years from the date of grant.

Key Figures

Direct Ordinary Shares: 79,947 shares Option series 1 underlying shares: 134,708 shares Option series 2 underlying shares: 95,292 shares +4 more

7 metrics

Direct Ordinary Shares 79,947 shares Directly held as of the Form 3 filing

Option series 1 underlying shares 134,708 shares Employee share options expiring March 14, 2027

Option series 2 underlying shares 95,292 shares Employee share options expiring August 30, 2026

Option series 3 underlying shares 230,000 shares Employee share options expiring May 15, 2026

Exercise price per option share $1.94 per share Converted from NIS 5.938 using NIS 3.060 to $1.00

Original exercise price (local currency) NIS 5.938 per share Current exercise price before FX conversion

FX rate used NIS 3.060 = $1.00 Conversion rate as of April 14, 2026

Key Terms

Employee share options (right to buy), Ordinary Shares, exercise price, vested, +1 more

5 terms

Employee share options (right to buy) financial

"security_title: "Employee share options (right to buy)""

Ordinary Shares financial

"underlying_security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

exercise price financial

"the current exercise price is NIS 5.938 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vested financial

"The options became fully vested as of March 14, 2025"

vests on a quarterly basis financial

"The options vest on a quarterly basis over four years"

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Cohen Amos

(Last) (First) (Middle)

85 MEDINAT HA-YEHUDIM STREET

(Street)

HERZLIYA 4676670

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Intercure Ltd. [ INCR ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	79,947	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee share options (right to buy)(1)	03/31/2021	03/14/2027	Ordinary Shares	134,708	$1.94	D
Employee share options (right to buy)(2)	09/30/2021	08/30/2026	Ordinary Shares	95,292	$1.94	D
Employee share options (right to buy)(3)	06/30/2022	05/15/2026	Ordinary Shares	230,000	$1.94	D

Explanation of Responses:

1. The options were granted on March 14, 2021, and the current exercise price is NIS 5.938 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 3.060 to USD $1.00 as of April 14, 2026, resulting in an exercise price of $1.94 per share. The options became fully vested as of March 14, 2025.

2. The options were granted on August 31, 2021, and the current exercise price is NIS 5.938 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 3.060 to USD $1.00 as of April 14, 2026, resulting in an exercise price of $1.94 per share. The options became fully vested as of August 31, 2025.

3. The options were granted on May 15, 2022, and the current exercise price is NIS 5.938 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 3.060 to USD $1.00 as of April 14, 2026, resulting in an exercise price of $1.94 per share. The options vest on a quarterly basis over four years from the date of grant.

	/s/ Amos Cohen	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Intercure (INCR) CFO Amos Cohen report in this Form 3?

Amos Cohen reports his existing stake in Intercure, including Ordinary Shares and multiple employee share options. The options give rights to buy Ordinary Shares at a fixed exercise price and have specific vesting schedules and expiration dates detailed in the filing footnotes.

How many Intercure employee share options does the CFO hold and at what price?

The CFO holds several employee share option series over Ordinary Shares, each with an exercise price of $1.94 per share. This dollar price reflects a NIS 5.938 exercise price converted at an exchange rate of NIS 3.060 to $1.00 as of April 14, 2026.

When do the Intercure (INCR) CFO’s option grants vest and expire?

Two option grants became fully vested by March 14, 2025 and August 31, 2025, respectively. A third grant dated May 15, 2022 vests quarterly over four years. The options expire on May 15, 2026, August 30, 2026, and March 14, 2027, depending on the grant.

What direct share ownership does the Intercure CFO report?

The filing shows Amos Cohen directly holds 79,947 Ordinary Shares of Intercure. This position is separate from his employee share options, which provide the right to acquire additional Ordinary Shares at a fixed exercise price if he chooses to exercise them.

How was the Intercure CFO option exercise price converted into U.S. dollars?

The current exercise price is NIS 5.938 per share, which was converted for this report using an exchange rate of NIS 3.060 to USD $1.00 as of April 14, 2026. This results in an exercise price of $1.94 per share in the filing.